King Hamad University Hospital, Bahrain
12
0
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
25.0%
3 terminated/withdrawn out of 12 trials
70.0%
-16.5% vs industry average
25%
3 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers
Role: collaborator
Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation
Role: collaborator
Hypoglycemia Biomarkers to Predict Timing of a Hypoglycemic Event
Role: collaborator
Date Fruit Effects in Type 2 Diabetes
Role: collaborator
Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
Role: lead
Intraarticular Platelet-rich Plasma Injections Versus Corticosteroid Injections in Primary Knee Osteoarthritis
Role: lead
Comparison of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy
Role: lead
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
Role: lead
The Incidence of Difficult Intubation in Obese Versus Non-obese Patients
Role: lead
Comparing Steroid Injections and Platelet Rich Plasma Injections in the Treatment of Plantar Fasciitis
Role: lead
Adjunctive Hyperbaric Oxygen Therapy (HBOT) for Lower Extermity Diabetic Ulcer:
Role: lead
Radiofrequency in Sacroiliac Arthropathy;Bipolar RF 6 Points Versus Monopolar RF at 6 and 3 Points
Role: lead
All 12 trials loaded